Loading...
Bless our stormwater system's heart (does it have one?). Seemed to hold up pretty well to me, Calvin. Stormwater is...

Welcome competition should lower EpiPen prices

CVS-EpiPen Generic

A rival generic version of Mylan's EpiPen has been approved for sale at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated before Congress because of its soaring cost to consumers.

Loading…

Friday, August 24, 2018

A couple of years ago Washington fell into anaphylactic shock over the high cost of EpiPens, devices that shoot adrenaline into someone having an allergic reaction. But the Trump Administration this week injected some overdue competition into the market that could lower prices for millions of Americans.

On Thursday the Food and Drug Administration approved the first generic competitor to Mylan ‘s EpiPen. The competing drug is manufactured by the Israeli pharmaceutical company Teva. One might wonder why a simple spring device filled with a cheap medicine didn’t have competitors, even decades after invention.

That was one question in 2016, when Congress hauled in Mylan CEO Heather Bresch to register outrage about the more than $600 list price of a two-pack of pens, which millions of kids and adults have to keep on hand. Not everyone pays full price after rebates and discounts, and some of the shock came from insurance designs that increased out-of-pocket costs. But the sticker price had increased more than 500 percent over 10 years.

Yet if Mylan kept prices high, the company had help from the FDA. The agency had not articulated standards for a class of drugs known as “complex generics” such as inhalers, which are more fraught than proving similarity to, say, a molecule pill. Mylan thus had no direct competition, though it now sells its own generic copy.

Other injectors are on the market but a pharmacist can’t substitute these versions thanks to issues as minor as the instructions for the device, though there is no clinical distinction. Companies like Teva have spent years ensnared in FDA processes, and in the meantime Mylan could increase prices without market consequences.

Before he became the current FDA Commissioner, Scott Gottlieb told Congress in 2016 about the “Catch-22” for drugmakers: They couldn’t win approval as a generic because another injection device wasn’t exactly the same as EpiPen, but other regulations also make it hard for competitors to get branded alternatives through the FDA’s new drug approval pathway.

Dr. Gottlieb has made clarity for such complex generics a priority at the FDA, and on Thursday he called the Teva device approval part of the agency’s efforts to remove barriers to competition. The approval is particularly timely amid supply shortages of EpiPens.

On all the evidence, products face the sharpest price decline when two generics are competing with the branded version. More drugmakers will jump into a market if they see an opportunity to make money and a regulatory agency that doesn’t construct needless barriers to entry.

At the time of the EpiPen brouhaha, Hillary Clinton called for a federal “consumer response team” that would rove around and penalize companies for price spikes. The laugh-cry moment is that the Trump Administration has flirted with a response from the Clinton playbook: Importing price controls from Europe for drugs with expired patents that lack competition.

President Trump seems to think that drugs are too expensive because of unfettered markets, but the EpiPen episode is a reminder: The real culprit is often not too much freedom but big business exploiting big government to keep prices high.

The Wall Street Journal

Loading…

Humans of Greenville

@HumansofGville

Local photographer Joe Pellegrino explores Greenville to create a photographic census of its people.

Editorials

September 18, 2018

"The youth use of e-cigs is rising very sharply," Food and Drug Administration Commissioner Scott Gottlieb said Wednesday, as he issued the federal government's most forceful warning yet that these electronic nicotine-delivery devices are hooking a generation of teenagers. He promised that…

Flavored Vaping Sales Ban

September 17, 2018

America shouldn’t be in the coup business. Period.

It’s a relief, then, to learn that the Trump administration chose not to aid rebellious leaders in Venezuela seeking to overthrow President Nicolás Maduro. But it’s worrisome to think that President Trump and his advisers…

Venezuela Nicolas Maduro

September 14, 2018

Over the past few decades, there has been a proliferation of criminal statutes and regulations carrying criminal penalties at the federal level. As Congress debates criminal justice reform, mens rea reform should be on the table.

For years, Sen. Orrin Hatch, R-Utah, has introduced and called for…

Trump Finance-3

September 13, 2018

It is tremendously sad and horrific to think about the forthcoming disaster and what it could bring to our communities and our neighbors to the south. We did nothing, really, other than live like we always have, to bring this on ourselves. Nevertheless, it is here.

Hurricane Florence, a major storm…

091218Sandbagging-4.jpg

September 12, 2018

You can add the name Jordan McNair to the list of college, high school and middle school players who might have needlessly died for the love of football.

A simple, well-known procedure — immersing McNair, 19, in a tub of ice water — when he collapsed at an off-season University of…

082918ECUFootball-5.jpg

September 11, 2018

By now, few might lift an eyebrow at President Trump’s crusade to delegitimize his own Justice Department and, specifically, his attorney general, Jeff Sessions. It long ago became clear that Trump regards federal law enforcement — as he sees all of government — as a political…

Trump Sessions

September 08, 2018

Republican state lawmakers decided last week to investigate the Cooper administration’s slow response to Hurricane Matthew relief in some of the state’s hardest-hit areas. That could be a useful exercise, if our legislators use what they find to fix real problems, and they don’t…

090518Cooper-HilmaGreens-2

September 07, 2018

When all of the state’s living former governors, including Pat McCrory, and all of the state’s former chief justices, including arch-conservative I. Beverly Lake Jr., come out against something unanimously, chances are it’s a bad idea.

Even the General Assembly had to notice…

North Carolina Ballot Battle

September 07, 2018

If President Donald Trump hadn’t bragged at a campaign rally in Alabama that if he were an NFL owner, he would fire any “son of a bitch” who knelt during the national anthem, would Colin Kaepernick be a face of Nike’s Just Do It campaign?

Would a black-and-white image of…

Kaepernick Nike

September 06, 2018

State Treasurer Dale Folwell asked a simple question: How much should North Carolina taxpayers be shelling out for state workers to receive care at UNC Health medical facilities?

The University of North Carolina Health Care System’s answer: That’s a secret.

State employees won’t…

103 stories in Editorials. Viewing 1 through 10.
«First Page   «Previous Page        
Page 1 of 11
        Next Page»   Last Page»